# CMS Fraud Rule Proposal Omits Life Sciences and Diagnostics Companies

By Riza Dagoc

Canonical URL: https://www.tokenpost.com/news/regulation/59593
Published: 2026-11-17T16:10:00.000Z
Updated: 2026-11-17T16:10:00.000Z
Section: Regulation

> The proposal covers Medicare, Medicaid, CHIP and the Health Insurance Marketplace. It also includes proposed changes to Medicare Advantage audits.

The Centers for Medicare & Medicaid Services (CMS) did not mention life sciences or diagnostic companies in its proposed Medicare and Medicaid fraud rule, which also covers other federal health programs.

CMS issued the CRUSH proposal Nov. 16. It covers Medicare, Medicaid, CHIP and the Health Insurance Marketplace, while its stated fraud focus is Medicare and Medicaid. The absence of a reference to life sciences or diagnostics describes the proposal’s text; it does not establish a final policy for either sector.

The rule also includes [proposed changes to Medicare Advantage risk-adjustment audits](<https://www.tokenpost.com/news/regulation/59452>). Those changes remain proposals and are not final.



## Links in this article

- [proposed changes to Medicare Advantage risk-adjustment audits](https://www.tokenpost.com/news/regulation/59452)
